{"id":"https://openalex.org/W142695009","doi":null,"title":"Short-course treatment of bacteremia with ceftriaxone monotherapy.","display_name":"Short-course treatment of bacteremia with ceftriaxone monotherapy.","publication_year":1990,"publication_date":"1990-02-01","ids":{"openalex":"https://openalex.org/W142695009","mag":"142695009","pmid":"https://pubmed.ncbi.nlm.nih.gov/1973718"},"language":"en","primary_location":{"id":"pmid:1973718","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1973718","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the Formosan Medical Association = Taiwan yi zhi","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110141143","display_name":"L S Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2803004286","display_name":"Taipei Veterans General Hospital","ror":"https://ror.org/03ymy8z76","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I2803004286"]}],"countries":["TW"],"is_corresponding":false,"raw_author_name":"L S Wang","raw_affiliation_strings":["Department of Medicine, Veterans General Hospital, Taipei, Taiwan, R.O.C"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Veterans General Hospital, Taipei, Taiwan, R.O.C","institution_ids":["https://openalex.org/I2803004286"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108596129","display_name":"D. L. Cheng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2803004286","display_name":"Taipei Veterans General Hospital","ror":"https://ror.org/03ymy8z76","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I2803004286"]}],"countries":["TW"],"is_corresponding":false,"raw_author_name":"D L Cheng","raw_affiliation_strings":["Veterans General Hospital-Taipei"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Veterans General Hospital-Taipei","institution_ids":["https://openalex.org/I2803004286"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018738012","display_name":"Daniel R. Hinthorn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2803004286","display_name":"Taipei Veterans General Hospital","ror":"https://ror.org/03ymy8z76","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I2803004286"]}],"countries":["TW"],"is_corresponding":false,"raw_author_name":"D R Hinthorn","raw_affiliation_strings":["Veterans General Hospital-Taipei"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Veterans General Hospital-Taipei","institution_ids":["https://openalex.org/I2803004286"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052153721","display_name":"CHIEN LIU","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2803004286","display_name":"Taipei Veterans General Hospital","ror":"https://ror.org/03ymy8z76","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I2803004286"]}],"countries":["TW"],"is_corresponding":false,"raw_author_name":"C Liu","raw_affiliation_strings":["Veterans General Hospital-Taipei"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Veterans General Hospital-Taipei","institution_ids":["https://openalex.org/I2803004286"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027425107","display_name":"Chang\u2010Phone Fung","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2803004286","display_name":"Taipei Veterans General Hospital","ror":"https://ror.org/03ymy8z76","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I2803004286"]}],"countries":["TW"],"is_corresponding":false,"raw_author_name":"C P Fung","raw_affiliation_strings":["Veterans General Hospital-Taipei"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Veterans General Hospital-Taipei","institution_ids":["https://openalex.org/I2803004286"]}]},{"author_position":"last","author":{"id":null,"display_name":"M C O'Connor","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2803004286","display_name":"Taipei Veterans General Hospital","ror":"https://ror.org/03ymy8z76","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I2803004286"]}],"countries":["TW"],"is_corresponding":false,"raw_author_name":"M C O'Connor","raw_affiliation_strings":["Veterans General Hospital-Taipei"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Veterans General Hospital-Taipei","institution_ids":["https://openalex.org/I2803004286"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I2803004286"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.01775719,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"89","issue":"2","first_page":"115","last_page":"20"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10218","display_name":"Sepsis Diagnosis and Treatment","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2706","display_name":"Critical Care and Intensive Care Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bacteremia","display_name":"bacteremia","score":0.9800000190734863},{"id":"https://openalex.org/keywords/ceftriaxone","display_name":"ceftriaxone","score":0.9869999885559082},{"id":"https://openalex.org/keywords/short-course-antibiotic-therapy","display_name":"short-course antibiotic therapy","score":0.8970000147819519},{"id":"https://openalex.org/keywords/monotherapy","display_name":"monotherapy","score":0.9620000123977661},{"id":"https://openalex.org/keywords/dosing-regimen","display_name":"dosing regimen","score":0.8489999771118164},{"id":"https://openalex.org/keywords/once-daily-dosing","display_name":"once-daily dosing","score":0.9210000038146973},{"id":"https://openalex.org/keywords/antimicrobial-susceptibility","display_name":"antimicrobial susceptibility","score":0.7490000128746033},{"id":"https://openalex.org/keywords/antibiotic-resistance","display_name":"antibiotic resistance","score":0.6779999732971191},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.574999988079071}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9542651176452637},{"id":"https://openalex.org/C2779443120","wikidata":"https://www.wikidata.org/wiki/Q650912","display_name":"Bacteremia","level":3,"score":0.9423048496246338},{"id":"https://openalex.org/C2776520383","wikidata":"https://www.wikidata.org/wiki/Q421713","display_name":"Ceftriaxone","level":3,"score":0.9318099617958069},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.6760597825050354},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4641929864883423},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.4345824420452118},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3784586787223816},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.0481012761592865},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002443","descriptor_name":"Ceftriaxone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002443","descriptor_name":"Ceftriaxone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004341","descriptor_name":"Drug Evaluation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011897","descriptor_name":"Random Allocation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016009","descriptor_name":"Chi-Square Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018805","descriptor_name":"Sepsis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:1973718","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1973718","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the Formosan Medical Association = Taiwan yi zhi","raw_type":"Clinical Trial"},{"id":"mag:142695009","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1973718","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1967546757","https://openalex.org/W47543939","https://openalex.org/W65472772","https://openalex.org/W2072566351","https://openalex.org/W2470379915","https://openalex.org/W7096651725","https://openalex.org/W4389031504","https://openalex.org/W2364307578","https://openalex.org/W1899671277","https://openalex.org/W4311758229"],"abstract_inverted_index":{"The":[0,88,94],"efficacy":[1],"of":[2,8,25,32,40,56,68,80,110,117,126,138,146,152,159,167,178],"short-course":[3,128,176],"ceftriaxone":[4,170],"monotherapy":[5,172],"in":[6,12,52,156],"treatment":[7,129,158,177],"bacteremia":[9,19,179],"was":[10],"evaluated":[11,96],"an":[13],"open":[14],"protocol.":[15],"Patients":[16],"with":[17,23,104,124],"laboratory-proven":[18],"were":[20,50,99],"randomly":[21],"treated":[22],"one":[24,125],"three":[26],"dosing":[27],"schedules":[28],"for":[29,175],"a":[30,139],"duration":[31],"5":[33],"to":[34,102],"7":[35],"days.":[36],"Fifty-seven":[37],"(62%)":[38],"out":[39,55,67,78],"the":[41,111,118,127,144,153,157],"92":[42],"evaluable":[43],"infections":[44,58,103,120],"had":[45,121,134],"successful":[46,122],"results.":[47],"Successful":[48],"responses":[49],"seen":[51],"20":[53],"(59%)":[54],"34":[57],"given":[59,70,82],"4":[60],"g":[61,72,84,169],"every":[62,73,85],"24":[63,86],"hours,":[64,75],"15":[65],"(54%)":[66],"28":[69],"2":[71,83,168],"12":[74],"and":[76,149],"22":[77],"(73%)":[79],"30":[81],"hours.":[87],"results":[89,123],"showed":[90],"no":[91,135],"significant":[92],"differences.":[93],"cases":[95],"as":[97,171],"failures":[98],"largely":[100],"due":[101],"resistant":[105],"organisms":[106],"or":[107],"inadequate":[108],"drainage":[109],"primary":[112,154],"infectious":[113],"foci.":[114],"Forty-nine":[115],"(94%)":[116],"52":[119],"regimens,":[130],"provided":[131],"that":[132,164],"they":[133],"factors":[136],"indicative":[137],"poor":[140],"prognosis.":[141],"We":[142],"stress":[143],"importance":[145],"anti-microbial":[147],"susceptibility":[148],"adequate":[150],"removal":[151],"foci":[155],"bacteremia.":[160],"Our":[161],"experience":[162],"indicates":[163],"once-daily":[165],"administrations":[166],"is":[173,182],"preferred":[174],"since":[180],"it":[181],"equally":[183],"effective,":[184],"but":[185],"more":[186],"economical":[187],"than":[188],"higher":[189],"dose":[190],"regimens.":[191]},"counts_by_year":[{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}